IP Library Granted Patent US 8,906,663
Granted Patent B2
US 8,906,663 · App. 13/678,884 · Granted Dec 9, 2014

Nitrilases

Inventors: David Weiner (San Diego, CA); Ellen Chi (Del Mar, CA); Jennifer Ann Chaplin (San Diego, CA); Aileen Milan (San Diego, CA); Jay M. Short (Del Mar, CA); Grace DeSantis (Del Mar, CA); Mark Madden (San Diego, CA); Mark J. Burk (San Diego, CA); Dan E. Robertson (Belmont, MA)
Assignee: Verenium Corporation
C12P7/42C12N15/00C12N15/815C12N15/81C12N15/74C12N15/70C12P21/00C12N9/78C12P13/004C12P13/04C12P41/006C12P7/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,663
App. No.
13/678,884
Granted
Dec 9, 2014
Kind
B2
Abstract

The invention relates to nitrilases and to nucleic acids encoding the nitrilases. In addition methods of designing new nitrilases and method of use thereof are also provided. The nitrilases have increased activity and stability at increased pH and temperature.

Claims (14)

1. An isolated, synthetic, or recombinant polynucleotide that encodes a polypeptide having nitrilase activity selected from a group consisting of:

(a) a variant of SEQ ID NO:189 having the nucleic acid sequence 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, identical to SEQ ID NO: 189, and the variant nucleic acid sequence encodes a polypeptide having a nitrilase activity; or

(b) a nucleic acid sequence completely complementary to (a).

2. An expression cassette, a vector, or a cloning vehicle comprising the nucleic acid sequence as forth in claim 1 .

3. A transformed non-human cell comprising:

(i) the expression cassette, the vector, or the cloning vehicle as set forth in claim 2 ;

(ii) the transformed cell of (i), where the cell is

(a) a gram negative bacteria, a gram positive bacteria, or a eukaryotic organism;

(b) an Escherichia coli;

(c) a Streptomyces diversa, Lactobacillus gasseri, Lactococcus lactis, Lactococcus cremoris , or a Bacillus subtilis ; or

(d) a Saccharomyces cerevisiae, Schizosaccharomyces pombe, Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha , or an Aspergillus niger.

4. A transgenic non-human organism comprising the nucleic acid of claim 1 .

5. An isolated, synthetic, or recombinant polynucleotide that encodes a polypeptide having nitrilase activity, wherein the polynucleotide is the nucleic acid sequence of SEQ ID NO: 189, wherein the nucleic acid is operably joined to a heterologous promoter.

6. A recombinant expression cassette, a vector, or a cloning vehicle comprising the nucleic acid sequence of SEQ ID NO:189, operably joined to a heterologous promoter as forth in claim 5 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: DESANTIS, GRACE; CHAPLIN, JENNIFER ANN; CHI, ELLEN; MILAN, AILEEN; SHORT, JAY M.; WEINER, DAVID; MADDEN, DARCY; BURK, MARK J.; ROBERTSON, DAN E.; DIVERSA CORPORATION
To: VERENIUM CORPORATION
Reel/Frame 031083/0944 →
Continuity (11)
Division 13169853 · Jun 27, 2011
Division 12629818 · Dec 2, 2009
Division 12397204 · Mar 3, 2009
Division 10146772 · May 15, 2002
Continuation In Part 09751299 · Dec 28, 2000
Provisional Application 60351336 · Jan 22, 2002
Provisional Application 60309006 · Jul 30, 2001
Provisional Application 60300189 · Jun 21, 2001
Provisional Application 60254414 · Dec 7, 2000
Provisional Application 60173609 · Dec 29, 1999
Related Publication 20130177949A1 · Jul 11, 2013